These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
96 related articles for article (PubMed ID: 18482833)
41. Intravitreal daunomycin induces multidrug resistance in proliferative vitreoretinopathy. Esser P; Tervooren D; Heimann K; Kociok N; Bartz-Schmidt KU; Walter P; Weller M Invest Ophthalmol Vis Sci; 1998 Jan; 39(1):164-70. PubMed ID: 9430558 [TBL] [Abstract][Full Text] [Related]
42. Anthracycline immunoconjugates prepared by a site-specific linkage via an amino-dextran intermediate carrier. Shih LB; Goldenberg DM; Xuan H; Lu H; Sharkey RM; Hall TC Cancer Res; 1991 Aug; 51(16):4192-8. PubMed ID: 1868440 [TBL] [Abstract][Full Text] [Related]
43. [The efficacy of autocatalytic casapse-3 driven by human telomerase reverse transcriptase promoter on human ovarian carcinoma]. Song Y; Shen K; Yu JR Zhonghua Yi Xue Za Zhi; 2007 Nov; 87(41):2919-24. PubMed ID: 18261307 [TBL] [Abstract][Full Text] [Related]
44. Drug-resistance associated alterations of cell surface antigen expression in a human anthracycline-resistant ovarian carcinoma cell line. Sedlák J; McGown A; Hrubisko M; Hunáková L; Chorváth B Neoplasma; 1994; 41(5):259-62. PubMed ID: 7854495 [TBL] [Abstract][Full Text] [Related]
45. Development of an oxime bond containing daunorubicin-gonadotropin-releasing hormone-III conjugate as a potential anticancer drug. Szabó I; Manea M; Orbán E; Csámpai A; Bosze S; Szabó R; Tejeda M; Gaál D; Kapuvári B; Przybylski M; Hudecz F; Mezo G Bioconjug Chem; 2009 Apr; 20(4):656-65. PubMed ID: 19296605 [TBL] [Abstract][Full Text] [Related]
46. Metformin inhibits the development and metastasis of ovarian cancer. Wu B; Li S; Sheng L; Zhu J; Gu L; Shen H; La D; Hambly BD; Bao S; Di W Oncol Rep; 2012 Sep; 28(3):903-8. PubMed ID: 22752027 [TBL] [Abstract][Full Text] [Related]
47. The role of reactive oxygen species in WP 631-induced death of human ovarian cancer cells: a comparison with the effect of doxorubicin. Rogalska A; Gajek A; Szwed M; Jóźwiak Z; Marczak A Toxicol In Vitro; 2011 Dec; 25(8):1712-20. PubMed ID: 21896327 [TBL] [Abstract][Full Text] [Related]
48. Monitoring of the interaction between U937 cells and electroactive daunomycin with an arginine-rich peptide. Sugawara K; Kadoya T; Kuramitz H Bioelectrochemistry; 2015 Oct; 105():95-102. PubMed ID: 26057596 [TBL] [Abstract][Full Text] [Related]
49. Effect of a conjugate of daunomycin and antibodies to rat alpha-fetoprotein on the growth of alpha-fetoprotein-producing tumor cells. Tsukada Y; Bischof WK; Hibi N; Hirai H; Hurwitz E; Sela M Proc Natl Acad Sci U S A; 1982 Jan; 79(2):621-5. PubMed ID: 6176999 [TBL] [Abstract][Full Text] [Related]
50. Immunotargeting of daunomycin to localized and metastatic human colon adenocarcinoma in athymic mice. Hurwitz E; Adler R; Shouval D; Takahashi H; Wands JR; Sela M Cancer Immunol Immunother; 1992; 35(3):186-92. PubMed ID: 1638555 [TBL] [Abstract][Full Text] [Related]
51. Biodistribution and tumour localisation of a daunomycin-monoclonal antibody conjugate in nude mice with human tumour xenografts. Pimm MV; Paul MA; Ogumuyiwa Y; Baldwin RW Cancer Immunol Immunother; 1988; 27(3):267-71. PubMed ID: 3180150 [TBL] [Abstract][Full Text] [Related]
52. Effects of Daunomycin and Daunomycin-protein conjugates on the ultrastructure of Trypanosoma rhodesiense. Williamson J; McLaren DJ; Brown JR Cell Biol Int Rep; 1983 Dec; 7(12):997-1005. PubMed ID: 6667510 [TBL] [Abstract][Full Text] [Related]
53. Sequence modification of heptapeptide selected by phage display as homing device for HT-29 colon cancer cells to improve the anti-tumour activity of drug delivery systems. Kiss K; Biri-Kovács B; Szabó R; Ranđelović I; Enyedi KN; Schlosser G; Orosz Á; Kapuvári B; Tóvári J; Mező G Eur J Med Chem; 2019 Aug; 176():105-116. PubMed ID: 31100648 [TBL] [Abstract][Full Text] [Related]
55. Isomer-dependent daunomycin release and in vitro antitumour effect of cis-aconityl-daunomycin. Reményi J; Balázs B; Tóth S; Falus A; Tóth G; Hudecz F Biochem Biophys Res Commun; 2003 Apr; 303(2):556-61. PubMed ID: 12659854 [TBL] [Abstract][Full Text] [Related]
56. Laser photochemotherapy with anthracyclines on cultured human squamous carcinoma cells. Paiva MB; Saxton RE; Letts G; Chung PS; Soudant J; Vanderwerf Q; Castro DJ Laryngoscope; 1996 Mar; 106(3 Pt 1):257-62. PubMed ID: 8614185 [TBL] [Abstract][Full Text] [Related]
57. Preparation of four daunomycin-monoclonal antibody 791T/36 conjugates with anti-tumour activity. Gallego J; Price MR; Baldwin RW Int J Cancer; 1984 Jun; 33(6):737-44. PubMed ID: 6376376 [TBL] [Abstract][Full Text] [Related]
58. Molecular pharmacology and antitumor activity of Zalypsis in several human cancer cell lines. Leal JF; García-Hernández V; Moneo V; Domingo A; Bueren-Calabuig JA; Negri A; Gago F; Guillén-Navarro MJ; Avilés P; Cuevas C; García-Fernández LF; Galmarini CM Biochem Pharmacol; 2009 Jul; 78(2):162-70. PubMed ID: 19427997 [TBL] [Abstract][Full Text] [Related]
59. A novel method of conjugation of daunomycin with antibody with a poly-L-glutamic acid derivative as intermediate drug carrier. An anti-alpha-fetoprotein antibody-daunomycin conjugate. Kato Y; Umemoto N; Kayama Y; Fukushima H; Takeda Y; Hara T; Tsukada Y J Med Chem; 1984 Dec; 27(12):1602-7. PubMed ID: 6209394 [TBL] [Abstract][Full Text] [Related]
60. Topoisomerases inhibition and DNA binding mode of daunomycin-oligoarginine conjugate. Visone V; Szabó I; Perugino G; Hudecz F; Bánóczi Z; Valenti A J Enzyme Inhib Med Chem; 2020 Dec; 35(1):1363-1371. PubMed ID: 32552137 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]